James Chih‐Hsin Yang
Texas Tech University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma(2009)8,200 cited
- → Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations(2013)3,181 cited
- → Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes(2002)2,800 cited
- → A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer(2003)2,702 cited
- → Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes(2006)2,560 cited
- → Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma(1988)2,321 cited